|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.97 USD | +1.43% |
|
-3.16% | +236.82% |
| 05-15 | Sutro Biopharma Shares Rise After Q1 Loss Narrows | MT |
| 05-15 | Wedbush Upgrades Sutro Biopharma to Outperform From Neutral, Boosts Price Target to $60 From $22 | MT |
| Capitalization | 646M 556M 508M 485M 889M 61.94B 903M 6.09B 2.36B 29.41B 2.42B 2.37B 102B | P/E ratio 2026 * |
-4.27x | P/E ratio 2027 * | -5.14x |
|---|---|---|---|---|---|
| Enterprise value | 626M 538M 492M 470M 861M 60.02B 875M 5.9B 2.28B 28.49B 2.35B 2.3B 99.26B | EV / Sales 2026 * |
15.1x | EV / Sales 2027 * | 15.3x |
| Free-Float |
97.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Sutro Biopharma, Inc.
| 17/07/24 | Indizes: Klein aber fein | |
| 16/07/24 | Indexen: klein is weer fijn | |
| 16/07/24 | Indici: ciò che è piccolo torna in auge | |
| 16/07/24 | Índices: Lo pequeño vuelve a ser bonito | |
| 16/07/24 | Indices : Ce qui est petit redevient mignon |
| 1 day | +1.43% | ||
| 1 week | -3.16% | ||
| Current month | +6.42% | ||
| 1 month | +23.52% | ||
| 3 months | +134.27% | ||
| 6 months | +358.42% | ||
| Current year | +236.82% |
| 1 week | 37.73 |  | 43.85 |
| 1 month | 31.55 | | 43.85 |
| Current year | 10.15 | | 43.85 |
| 1 year | 6.74 | | 43.85 |
| 3 years | 5.23 | | 61.3 |
| 5 years | 5.23 | | 237 |
| 10 years | 5.23 | | 283 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jane Chung
CEO | Chief Executive Officer | 55 | 12/03/2025 |
Gregory Chow
DFI | Director of Finance/CFO | 53 | 01/06/2025 |
Craig Berman
CTO | Chief Tech/Sci/R&D Officer | - | 20/05/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Petree
BRD | Director/Board Member | 70 | 31/07/2009 |
Joseph Lobacki
BRD | Director/Board Member | 67 | 31/01/2017 |
Michael Dybbs
BRD | Director/Board Member | 51 | 24/07/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.43% | -3.16% | +327.49% | -32.23% | 646M | |
| -1.59% | -1.30% | +34.56% | +76.78% | 50.1B | |
| +0.12% | -3.44% | +68.07% | +52.11% | 45.82B | |
| -5.60% | +7.69% | +60.22% | +488.04% | 23.66B | |
| -2.65% | -4.86% | -3.47% | -14.84% | 22.65B | |
| -2.20% | -0.36% | +38.69% | -24.45% | 17.8B | |
| +0.49% | +1.33% | +27.35% | -42.27% | 16.08B | |
| -5.32% | -13.33% | +36.21% | +207.57% | 14.14B | |
| -7.00% | -6.69% | -29.33% | +898.22% | 13.09B | |
| -2.84% | -5.57% | +28.16% | - | 13B | |
| Average | -2.51% | -2.32% | +58.79% | +178.77% | 21.7B | |
| Weighted average by Cap. | -2.31% | -1.31% | +37.01% | +152.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 41.37M 35.6M 32.55M 31.05M 56.93M 3.97B 57.87M 390M 151M 1.88B 155M 152M 6.56B | 33.25M 28.62M 26.16M 24.96M 45.76M 3.19B 46.52M 314M 121M 1.51B 125M 122M 5.28B |
| Net income | -142M -122M -112M -107M -195M -13.61B -198M -1.34B -518M -6.46B -532M -521M -22.51B | -150M -129M -118M -113M -207M -14.42B -210M -1.42B -549M -6.85B -564M -552M -23.85B |
| Net Debt | -20.08M -17.28M -15.8M -15.07M -27.64M -1.93B -28.09M -190M -73.35M -915M -75.36M -73.75M -3.19B | -138M -119M -108M -103M -190M -13.23B -193M -1.3B -504M -6.28B -517M -506M -21.87B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/05/26 | 38.97 $ | +1.43% | 261,210 |
| 14/05/26 | 38.42 $ | -2.98% | 117,495 |
| 13/05/26 | 39.60 $ | -3.20% | 219,661 |
| 12/05/26 | 40.91 $ | +4.07% | 224,695 |
| 11/05/26 | 39.31 $ | -2.31% | 198,259 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- STRO Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition